Swiss (SMI) Growth Pharmaceuticals & Biotech Stocks

UPDATED Feb 15, 2025

Discover Swiss Pharmaceuticals & Biotech Growth Stocks that are on the SMI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
PPGN
PolyPeptide Group
CHF 21.95-6.4%32.7%CHF 724.0mCHF 36.16PS2.4xE64.9%0%
NWRN
Newron Pharmaceuticals
CHF 10.124.1%21.9%CHF 202.0mCHF 15.64PS30.7xE40.4%n/a
GALD
Galderma Group
CHF 112.54-2.7%n/aCHF 26.7bCHF 107.26PS6.9xE36.6%n/a
SDZ
Sandoz Group
CHF 44.571.1%55.2%CHF 19.6bCHF 45.08PS2.1xE29.5%1.0%
BSLN
Basilea Pharmaceutica
CHF 40.15-0.4%8.8%CHF 486.7mCHF 77.25PS3.3xE29.5%0%
COPN
Cosmo Pharmaceuticals
CHF 64.302.1%-0.9%CHF 1.0bCHF 98.37PE15.7xE21.5%2.9%
LONN
Lonza Group
CHF 595.40-1.4%30.3%CHF 43.0bCHF 659.86PE67.6xE21.1%0.7%
ADXN
Addex Therapeutics
CHF 0.059-4.2%-18.1%CHF 5.8mn/aPS9.8xE18.5%n/a
SKAN
SKAN Group
CHF 76.20-1.8%-5.9%CHF 1.7bCHF 90.67PE53.1xE17.9%0.5%
IDIA
Idorsia
CHF 0.730.6%-46.9%CHF 137.8mCHF 1.00PS1.2xE17.8%n/a
BANB
Bachem Holding
CHF 56.701.3%-13.6%CHF 4.3bCHF 76.00PE37.4xE17.8%1.4%
ROG
Roche Holding
CHF 294.501.9%29.1%CHF 236.6bCHF 309.12PE28.3xE14.6%3.3%
TECN
Tecan Group
CHF 212.20-0.4%-40.3%CHF 2.7bCHF 283.83PE26.9xE13.9%1.4%
SFZN
Siegfried Holding
CHF 1,062.001.5%16.7%CHF 4.6bCHF 1,167.67PE35.4xE12.9%0.3%
NOVN
Novartis
CHF 95.37-1.5%7.8%CHF 188.4bCHF 102.09PE17.5xE7.0%3.6%
MOLN
Molecular Partners
CHF 4.24-3.9%6.1%CHF 156.2mCHF 9.75PS26xE-9.2%n/a
RLF
Relief Therapeutics Holding
CHF 3.454.9%102.9%CHF 43.3mn/aPS7.2xn/an/a
KURN
Kuros Biosciences
CHF 22.601.3%281.8%CHF 857.1mn/aPS16.3xn/an/a
SPEX
Spexis
CHF 0.01-16.7%-94.9%CHF 676.6kn/aPS1.1xn/an/a
DESN
Dottikon ES Holding
CHF 214.000.2%-8.9%CHF 3.0bCHF 350.00PE39.2xS16.4%0%
SANN
Santhera Pharmaceuticals Holding
CHF 16.40-0.7%64.8%CHF 206.6mCHF 25.00PE3.3xS-74.4%n/a
BIOV
BioVersys
CHF 36.102.7%n/aCHF 208.5mn/an/an/an/a
CURN
Curatis Holding
CHF 10.30-18.3%n/aCHF 50.0mCHF 20.00n/an/an/a
XLS
Xlife Sciences
CHF 20.80-1.9%-58.6%CHF 119.4mn/aPE5.6xn/an/a
Page 1 of 1